Login / Signup

Ex Vivo Prediction of Comprehensive Coagulation Potential Using Simulated Blood Concentrations of Emicizumab in Patients with Acquired Hemophilia A.

Masahiro TakeyamaShoko FurukawaKoji YadaKenichi OgiwaraNaruto ShimonishiYuto NakajimaKuniyoshi MizumachiMariko Noguchi-SasakiMidori ShimaKeiji Nogami
Published in: Thrombosis and haemostasis (2021)
 Based on ex vivo and in vitro data, emicizumab has the potential to be effective in clinical situations for PwAHAs.
Keyphrases
  • human health
  • electronic health record
  • big data
  • risk assessment
  • machine learning
  • artificial intelligence